Skip to Content

Sufentanil Injection

Last Updated: April 5, 2018
Status: Current

Sufentanil Injection

Products Affected - Description
  • Sufenta solution for injection, Akorn

50 mcg/mL, 1 mL ampule, 10 count (NDC 17478-0050-01)
50 mcg/mL, 2 mL ampule, 10 count (NDC 17478-0050-02)
50 mcg/mL, 5 mL ampule, 10 count (NDC 17478-0050-05)
 
Sufentanil solution for injection, Pfizer
50 mcg/mL, 1 mL vial, 10 count (NDC 00409-3382-21)
50 mcg/mL, 2 mL vial, 10 count, NDC 00409-3382-22)
 
Sufentanil solution for injection, West-Ward
50 mcg/mL, 5 mL ampule, 10 count (NDC 00641-6112-10)
Reason for the Shortage
    • Pfizer has sufentanil injection on shortage due to manufacturing delays.
    • Akorn has Sufenta injection on shortage due to increased demand for the product.
    • West-Ward did not provide a reason for the shortage.
Available Products
  • Sufentanil solution for injection, Pfizer
    50 mcg/mL, 5 mL vial, 10 count (NDC 00409-3382-25)

Estimated Resupply Dates

    • Pfizer has sufentanil 50 mcg/mL 1 mL and 2 mL vials on back order and the company estimates a release date of late-June 2018 for the 1 mL vials and late-April 2018 for the 2 mL vials.
    • Akorn has Sufenta 50 mcg/mL 1 mL, 2 mL, and 5 mL ampules on back order and the company estimates a release date of early-May 2018 for the 1 mL ampules and late-April 2018 for the 2 mL and 5 mL ampules.
    • West-Ward has sufentanil 50 mcg/mL 5 mL ampules available with an expiration date of < July 2018.

Implications for Patient Care

  • ASHP has an FAQ on the injectable opioid shortage. This discusses multiple issues including inventory and pharmacy operational strategies.

Updated

April 5, March 26 and 2, January 12, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.
Hide